Published in J Allergy Clin Immunol on October 01, 1974
The late phase of the immediate wheal and flare skin reaction. Its dependence upon IgE antibodies. J Clin Invest (1976) 2.19
Rhinovirus upper respiratory infection increases airway hyperreactivity and late asthmatic reactions. J Clin Invest (1989) 1.97
Cutaneous late-phase response to allergen. Mediator release and inflammatory cell infiltration. J Clin Invest (1989) 1.23
Significance of late reactions after bronchial challenge with house dust mite. Arch Dis Child (1976) 1.19
Allergen-specific IgG1 and IgG3 through Fc gamma RII induce eosinophil degranulation. J Clin Invest (1995) 1.14
The late reaction following bronchial provocation with house dust mite allergen. Dependence on arachidonic acid metabolism. Clin Exp Immunol (1983) 1.10
Relationship between exposure to domestic allergens and bronchial hyperresponsiveness in non-sensitised, atopic asthmatic subjects. Thorax (2005) 1.00
Effect of short-term systemic glucocorticoid treatment on human nasal mediator release after antigen challenge. J Clin Invest (1987) 0.95
Understanding allergic asthma from allergen inhalation tests. Can Respir J (2007) 0.93
The asthma syndrome: inciters, inducers, and host characteristics. Thorax (1981) 0.83
Conjunctival provocative tests: a model of human ocular allergy. Trans Am Ophthalmol Soc (1989) 0.82
Nocturnal thoracoabdominal asynchrony in house dust mite-sensitive nonhuman primates. J Asthma Allergy (2010) 0.80
Antigen provocation to the skin, nose and lung, in children with asthma; immediate and dual hypersensitivity reactions. Clin Exp Immunol (1982) 0.78
Cromoglycate and nedocromil: influence on airway reactivity. Mediators Inflamm (1994) 0.75
Allergy in pediatrics. Can Fam Physician (1985) 0.75
Immunologic mechanisms of hypersensitive lung diseases. Can Med Assoc J (1977) 0.75
Allergen-induced asthma. Can Respir J (2014) 0.75
Platelet activating factor (Paf-acether) may account for late-onset reactions to allergen inhalation. Agents Actions (1985) 0.75
A study on late allergic reactions to house dust mite in bronchial asthmatics. Korean J Intern Med (1986) 0.75
Failure to detect deposition of complement and immunoglobulin in allergen-induced late-phase skin reaction in atopic subjects. Clin Exp Immunol (1991) 0.75
Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy (1977) 14.37
SOME FACTORS INFLUENCING THE LONG-WAVE LIMIT OF PHOTOSYNTHESIS. Proc Natl Acad Sci U S A (1957) 6.35
Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med (1996) 5.69
Inhibitory effects of disodium cromoglycate on allergen-inhalation tests. Lancet (1968) 5.08
Reproducibility and comparison of responses to inhaled histamine and methacholine. Thorax (1978) 4.77
Bird breeder's (fancier's) lung. Lancet (1966) 4.68
Allergen-induced increase in non-allergic bronchial reactivity. Clin Allergy (1977) 4.42
Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax (1992) 4.30
The perception of breathlessness in asthma. Am Rev Respir Dis (1982) 4.17
Bronchial responsiveness to histamine or methacholine in asthma: measurement and clinical significance. J Allergy Clin Immunol (1981) 4.03
Mites and house-dust allergy. Lancet (1968) 4.01
Transient Changes in Cellular Gas Exchange and the Problem of Maximum Efficiency of Photosynthesis. Plant Physiol (1955) 3.94
The use of induced sputum to investigate airway inflammation. Thorax (1997) 3.85
Allergic reactions of the lungs to enzymes of Bacillus subtilis. Lancet (1969) 3.59
The assessment and treatment of asthma: a conference report. J Allergy Clin Immunol (1990) 3.40
Comparison of cardiorespiratory effects of isoprenaline and salbutamol in patients with bronchial asthma. Br Med J (1970) 3.25
Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations. Eur Respir J (2006) 3.09
Chronic cough: eosinophilic bronchitis without asthma. Lancet (1989) 3.07
Airway responsiveness to histamine and methacholine: relationship to minimum treatment to control symptoms of asthma. Thorax (1981) 3.06
Allergen-induced increase in bronchial responsiveness to histamine: relationship to the late asthmatic response and change in airway caliber. J Allergy Clin Immunol (1982) 2.84
Standardization of inhalation provocation tests: two techniques of aerosol generation and inhalation compared. Am Rev Respir Dis (1981) 2.75
Functional genomics of Neisseria meningitidis pathogenesis. Nat Med (2000) 2.73
The evaluation of a cell dispersion method of sputum examination. Clin Exp Allergy (1994) 2.58
Bronchial responsiveness to histamine: relationship to diurnal variation of peak flow rate, improvement after bronchodilator, and airway calibre. Thorax (1982) 2.53
Measurement of inflammatory indices in induced sputum: effects of selection of sputum to minimize salivary contamination. Eur Respir J (1996) 2.46
Acute asthma: emergency department management and prospective evaluation of outcome. CMAJ (1990) 2.45
Difference between end-tidal and arterial PCO2 in exercise. J Appl Physiol Respir Environ Exerc Physiol (1979) 2.31
Diagnostic testing in chronic urticaria and angioedema. CMAJ (1992) 2.27
Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics. Am Rev Respir Dis (1990) 2.23
Late asthmatic responses. Am Rev Respir Dis (1987) 2.05
Protective effect of drugs on histamine-induced asthma. Thorax (1977) 2.02
The radiological appearances in allergic broncho-pulmonary aspergillosis. Clin Radiol (1970) 1.97
Spontaneous and induced sputum to measure indices of airway inflammation in asthma. Am J Respir Crit Care Med (1996) 1.97
Late cutaneous allergic responses in isolated IgE-dependent reactions. J Allergy Clin Immunol (1973) 1.96
Nonvalidated food allergy tests. CMAJ (1988) 1.94
Induced sputum cell counts in healthy adults. Am J Respir Crit Care Med (2000) 1.93
Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis. Am J Respir Crit Care Med (1998) 1.90
BSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of Dermatologists. Rheumatology (Oxford) (2006) 1.86
Candida albicans precipitins in respiratory disease in man. J Allergy (1968) 1.82
Canadian Thoracic Society guidelines for occupational asthma. Can Respir J (1998) 1.80
Asthma and natural colds. Inflammatory indices in induced sputum: a feasibility study. Am J Respir Crit Care Med (1998) 1.72
The spectrum of IgE-mediated responses to latex. JAMA (1991) 1.71
Fatal reaction to peanut antigen in almond icing. CMAJ (1988) 1.70
Standardised methodology of sputum induction and processing. Eur Respir J Suppl (2002) 1.70
Induced sputum cell counts: their usefulness in clinical practice. Eur Respir J (2000) 1.69
Prednisone-dependent asthma: inflammatory indices in induced sputum. Eur Respir J (1999) 1.68
Asthma and increases in nonallergic bronchial responsiveness from seasonal pollen exposure. J Allergy Clin Immunol (1983) 1.67
Standardization of inhalation provocation tests: influence of nebulizer output, particle size, and method of inhalation. J Allergy Clin Immunol (1981) 1.66
Association of chronic urticaria and angioedema with thyroid autoimmunity. Arch Dermatol (1983) 1.65
Airway inflammation in symptomatic and asymptomatic children with methacholine hyperresponsiveness. Eur Respir J (1993) 1.65
Exacerbations of asthma without sputum eosinophilia. Thorax (1995) 1.63
Bronchoalveolar cell profiles of asthmatic and nonasthmatic subjects. Am Rev Respir Dis (1987) 1.62
Asthma, COPD and bronchitis are just components of airway disease. Eur Respir J (2006) 1.60
Bronchial responsiveness to inhaled histamine and exercise. J Allergy Clin Immunol (1979) 1.60
Selectivity of beta adrenoreceptor antagonist drugs assessed by histamine bronchial provocation. Clin Pharmacol Ther (1979) 1.60
Determinants of allergen-induced asthma: dose of allergen, circulating IgE antibody concentration, and bronchial responsiveness to inhaled histamine. Am Rev Respir Dis (1979) 1.57
Safety and efficacy of a CXCR2 antagonist in patients with severe asthma and sputum neutrophils: a randomized, placebo-controlled clinical trial. Clin Exp Allergy (2012) 1.55
Bronchial responsiveness to methacholine in chronic bronchitis: relationship to airflow obstruction and cold air responsiveness. Thorax (1984) 1.55
Dimethyl ethanolamine-induced asthma. Am Rev Respir Dis (1977) 1.53
Asthma induced by cold air and its relation to nonspecific bronchial responsiveness to methacholine. Am Rev Respir Dis (1982) 1.51
Trial of disodium cromoglycate in bronchial asthma. Br Med J (1969) 1.48
Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trial. Eur Respir J (1999) 1.48
Induced sputum: validity of fluid-phase IL-5 measurement. J Allergy Clin Immunol (2000) 1.47
Airway hyperresponsiveness. Relevance of random population data to clinical usefulness. Am Rev Respir Dis (1990) 1.45
A comparison of exhaled nitric oxide and induced sputum as markers of airway inflammation. J Allergy Clin Immunol (2000) 1.45
Diagnosing occupational asthma: use of induced sputum. Eur Respir J (1999) 1.42
Indirect airway challenges. Eur Respir J (2003) 1.42
Assessment and treatment of asthma. Can Fam Physician (1979) 1.41
Life-threatening asthma, urticaria, and angiooedema after ketoprofen. Lancet (1978) 1.40
Cellular characteristics of sputum from patients with asthma and chronic bronchitis. Thorax (1989) 1.40
Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment. Eur Respir J (2006) 1.40
Nonvalidated food allergy tests. CMAJ (1989) 1.39
Sputum in severe exacerbations of asthma: kinetics of inflammatory indices after prednisone treatment. Am J Respir Crit Care Med (1997) 1.38
Some technical factors influencing the induction of sputum for cell analysis. Eur Respir J (1995) 1.36